
MOTS-c + SS-31 + NAD+ + 5-Amino-1MQ Bundle
For in-vitro laboratory research use only. Not intended for human consumption, veterinary, diagnostic, or clinical use.
Description
This bundle brings together 1× MOTS-c 10 mg + 1× SS-31 10 mg + 1× NAD+ 500 mg + 1× 5-Amino-1MQ 10 mg in a single research bundle, priced around 20% below buying each vial separately. Each peptide is supplied in its own individual vial, so reconstitution and handling stay fully independent per compound.
Every vial is lyophilized research-grade powder at ≥ 99% HPLC purity, with a Certificate of Analysis available on request.
For laboratory research use only. Not for human or veterinary use.
MOTS-c 10 mg
MOTS-c (also written mots c) is a mitochondria-derived peptide consisting of 16 amino acids and encoded directly by mitochondrial DNA. It is classified as a mitochondrial-encoded signaling peptide that links mitochondrial activity with nuclear gene regulation.
Through activation of AMP-activated protein kinase (AMPK) via the AICAR pathway, MOTS-c coordinates multiple metabolic pathways, including glucose utilization, lipid oxidation, and energy expenditure. Under conditions of metabolic stress, MOTS-c translocates from the mitochondria to the nucleus, where it modulates the expression of stress adaptation genes through antioxidant response elements (ARE). These effects contribute to improved metabolic flexibility, resistance to insulin dysfunction, and protection against energy-metabolism disturbances. The peptide also demonstrates antioxidant and inflammatory-pathway properties at the cellular level.
MOTS-c is actively investigated across several research domains, including insulin sensitivity and glucose homeostasis, age-related functional decline, exercise physiology and skeletal muscle metabolism, bone remodeling, and inflammatory response modulation. Published studies have demonstrated that MOTS-c administration in animal models attenuates diet-induced metabolic-adaptation shifts and supports [metabolic regulation research](/product/slu-pp-332) ([Lee et al., 2015, Cell Metabolism](https://pubmed.ncbi.nlm.nih.gov/25738459/)). Circulating levels of MOTS-c have been shown to decline with age, while exercise significantly upregulates its expression in skeletal muscle. See also: NAD⁺, SS-31 10 mg, Epitalon
SS-31 10 mg
SS-31 (Elamipretide) is a synthetic, mitochondria-targeted tetrapeptide that selectively associates with cardiolipin within the inner mitochondrial membrane. It is classified as a cell-permeable aromatic-cationic peptide developed as a research tool for investigating mitochondrial bioenergetics, cristae architecture, and electron transport chain organization.
Through high-affinity binding to cardiolipin, SS-31 supports the structural integrity of respiratory chain supercomplexes and preserves cristae morphology under conditions of metabolic or oxidative stress. This targeted interaction has been associated with improved ATP synthesis, reduced reactive oxygen species generation, and protection of mitochondrial membrane potential in cellular and animal research models. Unlike conventional antioxidants that scavenge free radicals after they form, SS-31 is investigated for its ability to stabilize mitochondrial architecture at the source.
SS-31 is actively investigated across several research domains, including cardiac bioenergetics, neurodegeneration research, ischemia-reperfusion stress models, renal cellular-stress research, and [age-related mitochondrial decline](/product/nad). Published studies have demonstrated that SS-31 restores mitochondrial energetics in ischemic kidney models and protects cristae structure during reperfusion ([Birk et al., 2013, JASN](https://pubmed.ncbi.nlm.nih.gov/23813215/)). Its tetrapeptide structure enables rapid cellular uptake and selective localization to the inner mitochondrial membrane without disrupting membrane potential. See also: MOTS-c 10 mg, NAD⁺, Glutathione 600 mg
NAD+ 500 mg
NAD⁺ (Nicotinamide Adenine Dinucleotide) is an essential intracellular coenzyme present in every living cell and a central node in cellular bioenergetics. It is supplied as an investigational laboratory compound for use in longevity research, mitochondrial-pathway research, and redox-metabolism research.
Laboratory research studies have positioned NAD⁺ as a foundational metabolic cofactor that cycles between its oxidized (NAD⁺) and reduced (NADH) states, enabling efficient ATP production through glycolysis, the tricarboxylic acid cycle, and oxidative phosphorylation. Beyond its electron-carrier role, NAD⁺ serves as the obligate substrate for sirtuin deacylases (SIRT1·SIRT7), poly(ADP-ribose) polymerases (PARPs), and CD38, linking cellular energy state to gene-expression programs, DNA-maintenance signaling, and stress-adaptation responses (Chini et al., 2021, Cell Metabolism).
NAD⁺ is investigated across longevity research, neurobiology research, cardiovascular-pathway research, and metabolic-pathway research. Reported research observations include progressive age-associated decline in tissue NAD⁺ pools, modulation of mitochondrial efficiency under stress, and links between NAD⁺ bioavailability and axonal-integrity signaling via the NMNAT and SARM1 axis. The coenzyme is frequently studied alongside the NNMT inhibitor approach for probing nicotinamide salvage, and in parallel with mitochondrial-derived peptide signaling in energy-metabolism research models. NAD⁺ remains one of the most extensively studied coenzymes in modern biomedical research.
The compound is supplied as a lyophilized powder to ensure optimal stability during storage and handling.
5-Amino-1MQ 10 mg
5-Amino-1MQ (5-amino-1-methylquinolinium) is a research-grade small-molecule compound and a selective, membrane-permeable inhibitor of nicotinamide N-methyltransferase (NNMT). It is supplied as an investigational laboratory compound for use in metabolic-pathway research, adipose-biology research, and methyl-donor metabolism research.
Laboratory research studies have positioned 5-Amino-1MQ as a reference tool compound for examining how pharmacological NNMT inhibition reshapes intracellular nicotinamide and S-adenosyl-methionine (SAM) pools. Research models have characterised its binding to the NNMT substrate pocket, the resulting suppression of 1-methylnicotinamide (1-MNA) production, and downstream shifts in NAD⁺ salvage, lipid handling, and energy-metabolism research endpoints (Neelakantan et al., 2018, Biochemical Pharmacology).
Beyond enzyme kinetics, 5-Amino-1MQ is investigated in cellular and animal research models that explore adipocyte differentiation, lipid mobilisation, methyl-donor flux, and inflammatory-pathway signaling within metabolic tissues. Comparative metabolic-pathway research often pairs it with mitochondrial signaling tools and with ERR-targeted metabolic compounds to map overlapping energy-balance endpoints. The small-molecule scaffold, its membrane permeability, and its selectivity over related methyltransferases also make 5-Amino-1MQ a frequent subject of structure-activity research and chemical-biology studies of the NNMT pathway.
The compound is supplied as a lyophilized powder to ensure optimal stability during storage and handling.
Scientific Background
MOTS-c + SS-31 + NAD+ + 5-Amino-1MQ Bundle combines 4 research compounds: MOTS-c 10 mg, SS-31 10 mg, NAD+ 500 mg, 5-Amino-1MQ 10 mg. Scientific background for each component is documented below.
MOTS-c 10 mg
For decades, mitochondria were viewed primarily as energy-producing organelles. Advances in genomics later revealed that the mitochondrial genome encodes bioactive peptides capable of regulating systemic physiology. MOTS-c was identified within the 12S rRNA region of mitochondrial DNA as one of the first peptides shown to function as a circulating metabolic signal.
Subsequent studies demonstrated that MOTS-c is expressed across multiple tissues and can translocate to the nucleus in response to metabolic or oxidative stress. Its levels decline with aging, while exercise and metabolic challenges are associated with increased expression, suggesting a role in adaptive signalling.
This positioning at the intersection of mitochondrial biology, metabolic regulation, and aging research has made MOTS-c a peptide of considerable interest in laboratory investigations of energy homeostasis and cellular stress adaptation.
SS-31 10 mg
Mitochondria are the primary energy-producing organelles within cells and play a central role in oxidative phosphorylation, redox balance, and apoptotic signaling. Disruption of mitochondrial structure, cardiolipin composition, or cristae organization impairs electron transport efficiency, reduces ATP output, and increases oxidative stress. These features are commonly observed in cardiovascular research models, neurodegeneration research, renal cellular-stress models, and age-related functional decline.
SS-31 was developed at the Szeto-Schiller laboratory to directly address these mitochondrial vulnerabilities. Its aromatic, positively charged structure enables rapid cellular uptake independent of receptor binding, with selective concentration in the inner mitochondrial membrane. There it binds cardiolipin, a unique tetra-acyl phospholipid required for cristae formation and respiratory chain supercomplex assembly.
This structural mode of action distinguishes SS-31 from conventional antioxidants and positions it as a frequently used research tool in mitochondrial biology, bioenergetics, and laboratory investigations of energy homeostasis and cellular stress adaptation.
NAD+ 500 mg
NAD⁺ has been studied for over a century as a universal metabolic cofactor. Early research established its role as an electron acceptor and donor in core catabolic pathways, while later investigations expanded its function beyond bioenergetics into cellular-response signaling, stress resistance, and longevity biology.
Intracellular NAD⁺ is dynamically regulated through de novo biosynthesis, the salvage pathway, and consumption by NAD⁺-dependent enzymes. Age, metabolic stress, inflammatory signaling, and DNA damage are each associated with accelerated NAD⁺ depletion, while exercise and caloric restriction are linked to elevated NAD⁺ turnover.
This positioning of NAD⁺ at the intersection of metabolism, gene regulation, and stress biology has made it a molecule of considerable interest in laboratory investigations of energy homeostasis, neurodegenerative-pathway models, and aging research.
5-Amino-1MQ 10 mg
Nicotinamide N-methyltransferase (NNMT) is a cytosolic enzyme that transfers a methyl group from S-adenosyl-methionine (SAM) to nicotinamide, generating 1-methylnicotinamide (1-MNA) and S-adenosyl-homocysteine (SAH). Through this single reaction, NNMT sits at the intersection of NAD⁺ salvage, methyl-donor balance, and one-carbon metabolism.
Elevated NNMT expression has been reported in adipose tissue under energy-imbalance conditions and in several neoplastic-pathway research models, where it contributes to metabolic reprogramming and altered methylation landscapes. Targeting NNMT has therefore emerged as a focused research strategy for probing the metabolic consequences of nicotinamide depletion in cellular and animal model systems.
5-Amino-1MQ was developed as a selective, membrane-permeable NNMT inhibitor, enabling researchers to dissect NNMT-driven contributions to lipogenesis, adipocyte biology, and methyl-donor cycling in controlled in vitro and in vivo research settings.
Structure
MOTS-c + SS-31 + NAD+ + 5-Amino-1MQ Bundle is supplied as a homogeneous lyophilized mixture. Structural details for each compound:
MOTS-c 10 mg
SS-31 10 mg
NAD+ 500 mg
NAD⁺ Structure
5-Amino-1MQ 10 mg
Mechanism of Action
Each compound in MOTS-c + SS-31 + NAD+ + 5-Amino-1MQ Bundle engages distinct biochemical targets. Mechanism of action per compound:
MOTS-c 10 mg
1. Activation of AMPK Signaling
MOTS-c promotes cellular energy balance by activating the AICAR-AMPK pathway. This activation enhances glucose uptake, suppresses excessive gluconeogenesis, and increases fatty acid oxidation. Through these mechanisms, MOTS-c supports stable glucose homeostasis and improves insulin responsiveness.
2. Regulation of Nuclear Gene Expression
Under stress conditions, MOTS-c can enter the nucleus and interact with transcription factors involved in metabolic and inflammatory regulation. By influencing gene networks linked to glucose transport, mitochondrial biogenesis, and immune modulation, it acts as a messenger coordinating mitochondrial and nuclear responses.
3. Mitochondrial Remodeling and Stress Resistance
MOTS-c modulates mitochondrial dynamics by promoting fusion processes and regulating biogenesis-associated proteins. These changes enhance mitochondrial efficiency while limiting oxidative damage. Concurrently, MOTS-c upregulates antioxidant defenses, reducing reactive oxygen species and protecting cellular integrity.
4. Musculoskeletal and Endothelial Modulation
MOTS-c influences muscle differentiation and bone remodeling by regulating osteoblast and osteoclast activity, while also improving vascular endothelial performance and reducing inflammatory signaling in cardiac tissue under metabolic stress models.
Research Applications
Conclusion
MOTS-c represents a unique class of mitochondria-encoded peptides that function as systemic metabolic regulators. By integrating mitochondrial signaling with nuclear gene control, MOTS-c supports energy homeostasis, stress resistance, and age-related metabolic adaptation. Its diverse biological actions make it a valuable research target in metabolism, aging, and mitochondrial biology.
SS-31 10 mg
1. Selective Cardiolipin Binding
SS-31 concentrates in the inner mitochondrial membrane through high-affinity interaction with cardiolipin. This binding stabilizes the cardiolipin-cytochrome c complex, supports cristae curvature, and preserves the organization of respiratory chain supercomplexes essential for efficient electron transport.
2. Reduction of Mitochondrial Oxidative Stress
By stabilizing the cardiolipin-cytochrome c interaction, SS-31 limits cytochrome c peroxidase activity, a key driver of cardiolipin peroxidation. This action reduces electron leakage from the respiratory chain and lowers reactive oxygen species generation at the source of mitochondrial oxidant production.
3. Preservation of ATP Synthesis
Maintained cristae architecture and protected supercomplex organization support efficient proton gradient formation and ATP synthase function. SS-31 has been shown to preserve mitochondrial respiration and ATP output in cellular and tissue models exposed to ischemic or metabolic stress.
4. Support of Mitochondrial Quality Control
Research indicates that SS-31 influences mitochondrial dynamics by promoting fusion processes, limiting excessive fission, and supporting mitophagy of damaged mitochondria. These actions contribute to long-term mitochondrial quality control in high-energy-demand tissues.
Research Applications
Conclusion
SS-31 represents a structurally targeted approach to mitochondrial research, acting through selective cardiolipin binding rather than non-specific radical scavenging. By preserving cristae architecture, supporting respiratory chain organization, and limiting cardiolipin peroxidation, SS-31 supports stable mitochondrial bioenergetics across cardiac, renal, neuronal, and aging research models. Its mechanistic specificity makes it a valuable reference compound in mitochondrial biology and bioenergetic research.
NAD+ 500 mg
1. Regulation of Cellular Energy Metabolism
NAD⁺ is indispensable for glycolysis, the tricarboxylic acid cycle, and oxidative phosphorylation. By accepting and donating electrons across these pathways, NAD⁺ maintains efficient ATP production and supports tissues with high energy demand such as skeletal muscle, brain, and cardiac tissue. Cellular NAD⁺/NADH ratios provide a sensitive readout of nutrient state and mitochondrial flux.
2. DNA-Maintenance Signaling and Genomic Stability
NAD⁺ is the obligate substrate for poly(ADP-ribose) polymerases (PARPs), enzymes activated by DNA strand breaks. PARP-driven poly-ADP-ribosylation facilitates DNA-damage signaling, chromatin remodeling, and recruitment of repair complexes, linking NAD⁺ availability directly to long-term genomic integrity in research models.
3. Epigenetic and Stress Signaling via Sirtuins
Sirtuin enzymes (SIRT1·SIRT7) consume NAD⁺ to deacetylate histones and metabolic transcription factors, regulating gene expression, mitochondrial biogenesis, and adaptive stress signaling. Elevated NAD⁺ availability enhances sirtuin activity, which is correlated in research models with improved metabolic efficiency and oxidative-stress resistance.
4. Neuro-Metabolic Protection
NAD⁺ participates in axonal-maintenance pathways through NMNAT enzymes and the SARM1 axis. Proper NAD⁺ balance helps preserve neuronal architecture and function under metabolic or oxidative stress in laboratory neurodegeneration models, making NAD⁺ metabolism a frequent target of mechanistic neurobiology research.
Research Applications
Conclusion
NAD⁺ is a foundational coenzyme at the intersection of metabolism, cellular-response signaling, and stress adaptation. By coordinating energy production with genomic maintenance and gene-regulatory pathways, NAD⁺ supports cellular resilience and metabolic stability in research models. Its central role across aging, metabolic, cardiovascular, and neurobiological research makes it an indispensable compound in modern laboratory science.
5-Amino-1MQ 10 mg
1. Selective NNMT Inhibition
5-Amino-1MQ occupies the substrate-binding region of NNMT, competing with nicotinamide and reducing the enzymatic conversion of nicotinamide into 1-methylnicotinamide (1-MNA). This selective binding preserves intracellular nicotinamide pools and shifts methyl-donor flux, providing researchers a clean pharmacological handle on NNMT activity in cellular models.
2. Modulation of NAD⁺ Salvage and Energy Metabolism
By suppressing nicotinamide methylation, 5-Amino-1MQ increases the substrate pool available to nicotinamide phosphoribosyltransferase (NAMPT), supporting NAD⁺ salvage. Research models report associated shifts in NAD⁺-dependent sirtuin signaling, mitochondrial function, and oxidative-metabolism endpoints relevant to energy-metabolism research.
3. Effects on Lipid Handling and Adipocyte Biology
In vitro and in vivo research models indicate that NNMT inhibition by 5-Amino-1MQ is associated with reduced adipocyte differentiation, increased lipolysis, and lower lipid accumulation in adipose tissue. These observations make 5-Amino-1MQ a frequently used probe in metabolic-pathway research focused on energy balance and adipose remodeling.
4. Influence on Methyl-Donor and Inflammatory Signaling
NNMT activity drains the SAM methyl pool and has been linked to inflammatory-pathway signaling in metabolic tissues. By suppressing NNMT, 5-Amino-1MQ rebalances SAM and SAH pools and is reported in research models to modulate cytokine and chemokine signaling in adipose and stromal compartments.
Research Applications
Conclusion
5-Amino-1MQ is a selective NNMT inhibitor with broad relevance across metabolic and chemical-biology research. Through targeted modulation of nicotinamide methylation, methyl-donor flux, and downstream NAD⁺ salvage, it serves as a valuable tool compound for investigating energy-metabolism research, adipose biology, and NNMT-driven pathway research. Its continued use across cellular and animal model systems underscores its position as a reference NNMT-inhibitor scaffold.
References
Published references for each compound in MOTS-c + SS-31 + NAD+ + 5-Amino-1MQ Bundle, listed by component:
MOTS-c 10 mg
SS-31 10 mg
NAD+ 500 mg
5-Amino-1MQ 10 mg
Related products
Articles you might find useful

Semaglutide vs Tirzepatide: Research Comparison
Comparing semaglutide's selective GLP-1 action with tirzepatide's dual GIP/GLP-1 agonism, and w…

BPC-157: A Comprehensive Research Overview
BPC-157 is a 15-amino-acid peptide derived from gastric juice. A look at its structure, mechani…

Peptide Longevity Research: Cellular Aging Overview
Senescence, telomere shortening, mitochondrial decline: how research peptides give scientists n…



